SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-010809
Filing Date
2022-02-17
Accepted
2022-02-17 16:46:05
Documents
2
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1697
2 POA DOCUMENT poa.txt EX-24 3588
  Complete submission text file 0001209191-22-010809.txt   6710
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD., STE 420 MONTREAL A8 H4M 2X6
Business Address
Bharucha David (Reporting) CIK: 0001910985 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 22648844